A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler · Schizophrenia Bulletin · 1987 · 21K citations · Full text

Psychopathology, Psychiatry, Psychotic Disorder +11

The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients

Ole Christian Lingjærde, U. G. Ahlfors, Per Bech et al. · Acta Psychiatrica Scandinavica · 1987 · 1.7K citations

Neuroleptic‐treated Patients, Cross‐sectional Study, Psychiatry +11

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial

BMC Psychiatry · 2017 · 200 citations · Full text

Using a pharmacogenomic algorithm to guide the treatment of depression

Daniel K. Hall‐Flavin, Joel G Winner, Josiah D. Allen et al. · Translational Psychiatry · 2012 · 178 citations · Full text

The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy

Diana Brixner, Eman Biltaji, Adam P. Bress et al. · Journal of Medical Economics · 2015 · 148 citations